Annual CFO
-$19.93 M
-$3.19 M-19.06%
31 December 2023
Summary:
Purple Biotech annual cash flow from operations is currently -$19.93 million, with the most recent change of -$3.19 million (-19.06%) on 31 December 2023. During the last 3 years, it has fallen by -$7.83 million (-64.78%). PPBT annual CFO is now -3791.60% below its all-time high of -$512.00 thousand, reached on 31 December 2013.PPBT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.29 M
+$681.00 K+17.13%
01 September 2024
Summary:
Purple Biotech quarterly cash flow from operations is currently -$3.29 million, with the most recent change of +$681.00 thousand (+17.13%) on 01 September 2024. Over the past year, it has increased by +$361.00 thousand (+9.87%). PPBT quarterly CFO is now -38.33% below its all-time high of -$2.38 million, reached on 01 September 2015.PPBT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$17.34 M
+$361.00 K+2.04%
01 September 2024
Summary:
Purple Biotech TTM cash flow from operations is currently -$17.34 million, with the most recent change of +$361.00 thousand (+2.04%) on 01 September 2024. Over the past year, it has increased by +$1.82 million (+9.51%). PPBT TTM CFO is now -627.75% below its all-time high of -$2.38 million, reached on 01 September 2015.PPBT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PPBT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.1% | +9.9% | +9.5% |
| 3 y3 years | -64.8% | -12.1% | -50.8% |
| 5 y5 years | -135.0% | - | - |
PPBT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.8% | at low | -12.1% | +45.7% | -50.8% | +13.0% |
| 5 y | 5 years | -257.0% | at low | -12.1% | +45.7% | -398.4% | +13.0% |
| alltime | all time | -3791.6% | at low | -38.3% | +45.7% | -627.8% | +13.0% |
Purple Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.29 M(-17.1%) | -$17.34 M(-2.0%) |
| June 2024 | - | -$3.98 M(-21.8%) | -$17.70 M(-6.6%) |
| Mar 2024 | - | -$5.08 M(+2.0%) | -$18.94 M(-4.9%) |
| Dec 2023 | -$19.93 M(+19.1%) | -$4.98 M(+36.3%) | -$19.93 M(+4.0%) |
| Sept 2023 | - | -$3.66 M(-30.0%) | -$19.16 M(+0.2%) |
| June 2023 | - | -$5.22 M(-13.9%) | -$19.12 M(+8.7%) |
| Mar 2023 | - | -$6.06 M(+43.9%) | -$17.60 M(+5.2%) |
| Dec 2022 | -$16.73 M(+9.7%) | -$4.21 M(+16.4%) | -$16.73 M(+2.8%) |
| Sept 2022 | - | -$3.62 M(-2.1%) | -$16.27 M(+4.4%) |
| June 2022 | - | -$3.70 M(-28.8%) | -$15.59 M(-8.1%) |
| Mar 2022 | - | -$5.20 M(+38.6%) | -$16.97 M(+11.3%) |
| Dec 2021 | -$15.25 M | -$3.75 M(+27.7%) | -$15.25 M(+32.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$2.94 M(-42.1%) | -$11.50 M(+34.4%) |
| June 2021 | - | -$5.08 M(+46.1%) | -$8.56 M(+146.1%) |
| Mar 2021 | - | -$3.48 M(+46.0%) | -$3.48 M(+46.0%) |
| Dec 2020 | -$12.09 M(+116.7%) | - | - |
| Dec 2019 | -$5.58 M(-34.2%) | - | - |
| Dec 2018 | -$8.48 M(-1.7%) | - | - |
| Dec 2017 | -$8.63 M(+37.8%) | - | - |
| Dec 2016 | -$6.26 M(+89.3%) | - | - |
| Dec 2015 | -$3.31 M(-26.9%) | - | - |
| Sept 2015 | - | -$2.38 M(-32.4%) | -$2.38 M(-32.4%) |
| Dec 2014 | -$4.53 M(+784.0%) | - | - |
| Sept 2014 | - | -$3.52 M | -$3.52 M |
| Dec 2013 | -$512.00 K | - | - |
FAQ
- What is Purple Biotech annual cash flow from operations?
- What is the all time high annual CFO for Purple Biotech?
- What is Purple Biotech annual CFO year-on-year change?
- What is Purple Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Purple Biotech?
- What is Purple Biotech quarterly CFO year-on-year change?
- What is Purple Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Purple Biotech?
- What is Purple Biotech TTM CFO year-on-year change?
What is Purple Biotech annual cash flow from operations?
The current annual CFO of PPBT is -$19.93 M
What is the all time high annual CFO for Purple Biotech?
Purple Biotech all-time high annual cash flow from operations is -$512.00 K
What is Purple Biotech annual CFO year-on-year change?
Over the past year, PPBT annual cash flow from operations has changed by -$3.19 M (-19.06%)
What is Purple Biotech quarterly cash flow from operations?
The current quarterly CFO of PPBT is -$3.29 M
What is the all time high quarterly CFO for Purple Biotech?
Purple Biotech all-time high quarterly cash flow from operations is -$2.38 M
What is Purple Biotech quarterly CFO year-on-year change?
Over the past year, PPBT quarterly cash flow from operations has changed by +$361.00 K (+9.87%)
What is Purple Biotech TTM cash flow from operations?
The current TTM CFO of PPBT is -$17.34 M
What is the all time high TTM CFO for Purple Biotech?
Purple Biotech all-time high TTM cash flow from operations is -$2.38 M
What is Purple Biotech TTM CFO year-on-year change?
Over the past year, PPBT TTM cash flow from operations has changed by +$1.82 M (+9.51%)